Literature DB >> 4176151

Platelet-phosphohexokinase levels in Down's syndrome.

J C Doery, J Hirsh, O M Garson, G C de Gruchy.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4176151     DOI： 10.1016/s0140-6736(68)91057-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody.

Authors:  M Van Keuren; H Drabkin; I Hart; D Harker; D Patterson; S Vora
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

2.  Phosphofructokinase and chromosome 21.

Authors:  R B Layzer; C J Epstein
Journal:  Am J Hum Genet       Date:  1972-09       Impact factor: 11.025

3.  Diminished activity of platelet monoamine oxidase in Down's syndrome.

Authors:  P F Benson; J Southgate
Journal:  Am J Hum Genet       Date:  1971-03       Impact factor: 11.025

4.  Blood cell enzymes in translocation Down's syndrome.

Authors:  R S Sparkes; M A Baughan
Journal:  Am J Hum Genet       Date:  1969-09       Impact factor: 11.025

Review 5.  Growing points in cell pathology. Cytogenetic aspects.

Authors:  P E Polani
Journal:  Proc R Soc Med       Date:  1970-09

6.  Blood cell phosphofructokinase in Down's syndrome.

Authors:  M M Conway; R B Layzer
Journal:  Humangenetik       Date:  1970

7.  Assignment of the human gene for liver-type 6-phosphofructokinase isozyme (PFKL) to chromosome 21 by using somatic cell hybrids and monoclonal anti-L antibody.

Authors:  S Vora; U Francke
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.